| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000030707 |
| Receipt No. | R000035049 |
| Scientific Title | Verification of clinical effect of pressure waves (diffusion shock wave) treatment for Achilles / patellar tendinopathy |
| Date of disclosure of the study information | 2018/01/11 |
| Last modified on | 2020/01/23 (Ver. 3) |
| Basic information | ||
| Public title | Verification of clinical effect of pressure waves (diffusion shock wave) treatment for Achilles / patellar tendinopathy | |
| Acronym | Verification of clinical effect of pressure waves (diffusion shock wave) treatment for Achilles / patellar tendinopathy | |
| Scientific Title | Verification of clinical effect of pressure waves (diffusion shock wave) treatment for Achilles / patellar tendinopathy | |
| Scientific Title:Acronym | Verification of clinical effect of pressure waves (diffusion shock wave) treatment for Achilles / patellar tendinopathy | |
| Region |
|
|
| Condition | |||
| Condition | Achilles tendinopathy
patellar tendinopathy |
||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | It is to confirm the effect of diffusion type Shockwave on tendonopathy of patellar and Achilles by comparison result of single blind comparison. By showing its effectiveness of it, evaluate the possibility as a new treatment for athletes who can not perform surgery to avoid interruption. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluate IKDC questionnaire, VAS, physical remarks in 3 months |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intervention of extracorporeal shock wave 4 times a week.Output 2-4 bar, 12 Hz, 2000 shot | |
| Interventions/Control_2 | Intervention of placebo 4 times a week.
2000shot |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Pain continues for 1 month or more after onset.
Subjects who do not wish to conduct medication treatment such as corticosteroid injection or surgery. |
|||
| Key exclusion criteria | Those who have undergone major operation of the knee in the past. | |||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Juntendo University School of Medicine | ||||||
| Division name | Orthopedics | ||||||
| Zip code | |||||||
| Address | 3-1-3 Hongo, Bunkyo-ku, Tokyo | ||||||
| TEL | 03-3813-3111 | ||||||
| hi-ikeda@juntendo.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Juntendo University nerima hospital | ||||||
| Division name | Orthopedics | ||||||
| Zip code | |||||||
| Address | 3-1-10 Takanodai, Nerima-ku, Tokyo | ||||||
| TEL | 03-5923-3111 | ||||||
| Homepage URL | |||||||
| kobakei44@gmail.com | |||||||
| Sponsor | |
| Institute | Juntendo university School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Sakai medical |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000035049 |